Se rendre au contenu
  1. All Products
  2. Biosimilar Antibodies
  3. Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific
-
Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

https://assay.labm.com/web/image/product.template/472749/image_1920?unique=02640f7
(0 avis)
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.

1.234.567,00 € 1234567.0 EUR 1.234.567,00 € Hors taxes

1.234.567,00 € Hors taxes

Not Available For Sale

Cette combinaison n'existe pas.

This content will be shared across all product pages.


Hieff NGS

Contactez-nous

Conditions générales
Garantie satisfait ou remboursé de 30 jours
Expédition : 2-3 jours ouvrables

Partager

Référence interne: GMA-CD3E
URL de site web: /shop/gma-cd3e-gentaur-epcoritamab-anti-cd3e-cd20-ms4a1-bispecific-472749

Our Products !

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.